Daymark Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Sell
5,736
-37
-0.6% -$3.4K 0.02% 414
2025
Q4
$519K Sell
5,773
-103
-2% -$9.77K 0.02% 383
2025
Q3
$579K Sell
5,876
-956
-14% -$94.7K 0.02% 355
2025
Q2
$623K Sell
6,832
-200
-3% -$19.3K 0.02% 318
2025
Q1
$796K Sell
7,032
-304
-4% -$32.5K 0.03% 272
2024
Q4
$775K Buy
7,336
+89
+1% +$9.55K 0.03% 268
2024
Q3
$782K Sell
7,247
-84
-1% -$9.17K 0.03% 276
2024
Q2
$796K Buy
7,331
+8
+0.1% +$943 0.04% 270
2024
Q1
$966K Buy
7,323
+449
+7% +$56.1K 0.05% 203
2023
Q4
$837K Sell
6,874
-13
-0.2% -$1.45K 0.05% 201
2023
Q3
$773K Buy
6,887
+4,030
+141% +$512K 0.05% 195
2023
Q2
$416K Buy
+2,857
New +$388K 0.03% 256

Other funds holding ZBH

Daymark Wealth Partners's ZBH Position: Q1 2026 in Review

Daymark Wealth Partners reduced its Zimmer Biomet (ZBH) stake by 0.64% in Q1 2026, selling an estimated $3.4K and leaving 5,736 shares worth $519K. The position accounts for 0.02% of the portfolio, ranked #414.

Daymark Wealth Partners first reported a position in ZBH in Q2 2023 and has held it in 12 quarters since. The position peaked at $966K in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Daymark Wealth Partners held 5,736 shares of Zimmer Biomet worth $519K as of Q1 2026.
  • Daymark Wealth Partners sold 37 Zimmer Biomet shares in Q1 2026, an estimated $3.4K.
  • Zimmer Biomet made up 0.02% of Daymark Wealth Partners's portfolio in Q1 2026, its #414 holding.
  • Daymark Wealth Partners first reported a position in Zimmer Biomet in Q2 2023 and has held it in 12 quarters since.
  • Daymark Wealth Partners's Zimmer Biomet position peaked at $966K in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.